AssuredPartners Investment Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$369K Sell
4,716
-1,419
-23% -$114K 0.04% 308
2026
Q1
$529K Sell
6,135
-2,072
-25% -$198K 0.06% 243
2025
Q4
$788K Buy
8,207
+5,506
+204% +$535K 0.12% 164
2025
Q3
$257K Buy
+2,701
New +$248K 0.06% 224
2025
Q2
– Sell
-11,555
Closed -$1.04M – 300
2025
Q1
$1.04M Buy
11,555
+34
+0.3% +$3.04K 0.2% 123
2024
Q4
$920K Buy
+11,521
New +$997K 0.18% 129

Other funds holding MDT

AssuredPartners Investment Advisors's MDT Position: Q2 2026 in Review

AssuredPartners Investment Advisors reduced its Medtronic (MDT) stake by 23% in Q2 2026, selling an estimated $114K and leaving 4,716 shares worth $369K. The position accounts for 0.04% of the portfolio, ranked #308.

AssuredPartners Investment Advisors first reported a position in MDT in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.04M in Q1 2025. 2,146 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • AssuredPartners Investment Advisors held 4,716 shares of Medtronic worth $369K as of Q2 2026.
  • AssuredPartners Investment Advisors sold 1,419 Medtronic shares in Q2 2026, an estimated $114K.
  • Medtronic made up 0.04% of AssuredPartners Investment Advisors's portfolio in Q2 2026, its #308 holding.
  • AssuredPartners Investment Advisors first reported a position in Medtronic in Q4 2024 and has held it in 6 quarters since.
  • AssuredPartners Investment Advisors's Medtronic position peaked at $1.04M in Q1 2025.
  • 2,146 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on AssuredPartners Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.